5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) is an intermediate in de novo purine synthesis and a molecule that can activate AMPK in Biological Chemistry II.
5-aminoimidazole-4-carboxamide ribonucleotide, usually shortened to AICAR, is a mid-pathway intermediate in de novo purine biosynthesis. In Biological Chemistry II, you meet it as part of the route that builds a purine ring from small metabolic pieces instead of recycling an old base.
AICAR sits after 5-aminoimidazole ribonucleotide (AIR) and before later steps that eventually lead to AMP production. The enzyme AICAR transformylase adds a formyl group to AICAR, pushing the pathway forward. That means AICAR is not an endpoint, it is a checkpoint where the cell commits more resources to making purine nucleotides.
The ribonucleotide part matters too. AICAR already contains ribose, so it is part of the nucleotide framework, not just the free base. In purine synthesis, the cell is assembling the ring while it is already attached to ribose phosphate, which is why the pathway is tightly linked to overall nucleotide metabolism.
AICAR also shows up outside classic nucleotide synthesis because it can activate AMP-activated protein kinase, or AMPK. This is why the molecule gets attention in metabolism units. AMPK is the cell’s energy sensor, so when AICAR mimics a low-energy signal, it can shift metabolism toward fuel use and away from energy storage.
That second role can be confusing at first: one molecule is both a biosynthetic intermediate and a signaling-related compound. In the classroom, though, those are two different contexts. In the pathway context, AICAR is a stepping-stone toward AMP. In the signaling context, AICAR is used as a tool to probe energy homeostasis and downstream metabolic responses.
A useful way to think about AICAR is to ask two questions. First, where is it in the purine pathway? Second, what does the cell do when AICAR accumulates or is supplied experimentally? Those two answers connect nucleotide synthesis to energy regulation, which is exactly the kind of cross-talk Biological Chemistry II likes to test.
AICAR matters because it links purine biosynthesis to cellular energy sensing. In a purine pathway question, recognizing AICAR tells you where the cell is in the sequence of reactions and which enzyme comes next. In a metabolism question, the same molecule can point you toward AMPK signaling, fatty acid oxidation, and increased glucose uptake.
This makes AICAR useful for connecting two big course ideas: building nucleotides and responding to energy stress. If a cell cannot keep up with nucleotide demand, the pathway stalls at intermediates like AICAR. If AICAR is acting as an AMPK activator, the cell behaves as if energy is low, which shifts metabolism toward making ATP and conserving resources.
AICAR also helps you separate pathway chemistry from signaling chemistry. Some exam questions or lab discussions will ask about the enzyme step, while others will ask about downstream effects in metabolism experiments. If you know which role is being tested, you can trace the right cause-and-effect chain instead of mixing the two together.
Keep studying Biological Chemistry II Unit 5
Visual cheatsheet
view galleryAMP-activated protein kinase (AMPK)
AICAR is often discussed with AMPK because it can activate this energy sensor. That makes AICAR useful in metabolism experiments where the goal is to mimic low-energy conditions and watch changes in glucose uptake or fatty acid oxidation. The connection is signaling, not purine assembly, so pay attention to which question you are answering.
Nucleotide synthesis
AICAR is one intermediate in the de novo construction of purine nucleotides. It sits in the middle of the pathway, so it helps show that nucleotide synthesis is a stepwise process with specific enzyme-catalyzed transfers. If you can place AICAR in order, you are usually tracking the pathway correctly.
Adenylosuccinate synthetase
AICAR moves toward AMP production through later purine steps that include adenylosuccinate formation. This term is a good reminder that AICAR does not become AMP in one jump. The pathway branches through additional enzymes, and those steps are often where regulation and energy use become easier to test.
Glutamine phosphoribosyl amidotransferase
This enzyme works earlier in de novo purine synthesis than AICAR does. It helps build the pathway foundation that eventually leads to intermediates like AICAR. When you map the pathway, this term is useful for comparing the early committed step with a later mid-pathway intermediate.
Quiz and problem-set questions usually ask you to do one of three things with AICAR: place it in the purine synthesis pathway, identify the enzyme that acts on it, or explain what happens when it activates AMPK. A pathway diagram may show AIR converting to AICAR and then ask you to name the next metabolic direction, which is toward AMP. A metabolism question may describe increased glucose uptake or fatty acid oxidation and expect you to connect that response to AMPK signaling. If you see AICAR in a lab or case-based prompt, think about whether the question is testing nucleotide synthesis, energy sensing, or both.
AICAR is a purine biosynthesis intermediate, not a final nucleotide product.
It appears after AIR in the de novo pathway and before later steps that lead to AMP.
AICAR can also activate AMPK, so it connects nucleotide metabolism with energy signaling.
In Biological Chemistry II, the big skill is knowing whether a question is asking about pathway position or metabolic effect.
If you can place AICAR in order, you can usually follow the rest of the purine synthesis logic.
AICAR is a mid-pathway intermediate in de novo purine biosynthesis. It also matters in metabolism because it can activate AMPK, which makes cells act like they are in a low-energy state. That is why it shows up in both nucleotide pathway questions and signaling questions.
AICAR comes after AIR in the de novo purine pathway. An enzyme called AICAR transformylase acts on it, and the pathway continues toward AMP production. If you are drawing the sequence, AICAR is a middle step, not the beginning or the end.
AICAR is used as a chemical mimic of low-energy conditions in cells, so it can trigger AMPK-related responses. That shifts metabolism toward energy-producing pathways, including increased glucose uptake and fatty acid oxidation. In class, this is usually discussed as a signaling effect rather than a purine synthesis step.
No. AICAR is an intermediate in purine biosynthesis, while AMP is a finished nucleotide product. They are connected through the pathway, but they are not interchangeable, and AICAR has its own role in AMPK signaling that AMP does not replace in the same way.